Downloads: 132 | Monthly Hits: ⮙1
Research Paper | Pathology | India | Volume 9 Issue 9, September 2020
Pheochromocytoma - Histopathological and Clinical Update
Dr. Asima Ajaz, Dr. Huzaifa Tak, Dr Iqbal Lone
Background: The pheochromocytoma or paraganglioma PPGL is a metabolically active tumor originating from the chromaffin cells of adrenal medulla (pheochromocytomas) or from sympathetic or parasympathetic autonomic ganglia (paragangliomas). The exact incidence of pheochromocytoma is unknown, but it is estimated to occur in 2–8 cases per 1 million people per year. The estimated prevalence in hypertensive adults is thought to range from 0.1 to 0.6 %. The foremost investigation is ususally increased urinary and plasma levels of catecholamines and their metabolites (metanephrines, normetanephrines & VMA). Histopathological and IHC features are accustomed to authenticate the diagnosis. Aim: In this study, the most frequently diagnosed tumor of adrenal gland-Pheochromocytoma along with their detailed histopathological, biochemical and clinical characterstics were studied in detail. Material and Method: A retrospective 5 year study was carried out. Brief clinical history was taken along with other relevant parameters. Histopathological data was collected and relevant details were noted. The clinical and findings of H & E sections, special stains and IHC were compiled to arrive at a final diagnosis. Results: Out of 70 cases of adrenal masses, pheochromocytoma (31 cases) was the most common tumor observed. The most common symptom was hypertension. CT scan done on 28 cases showed greater enhancement on contrast phase. The 24-hr urinary levels of VMA was elevated in 16 (51.6 %). Confluent necrosis was present in 14 cases and 3 cases showed vascular invasion histologically. Pass score was ≥4 in 9cases and <4 in remaining 22cases. IHC panel used show positivity for Chromogranin, S-100, synaptophysin. Conclusion: We conclude that the following clinicopathological parameters should be taken into account for proper diagnosis and risk assessment of malignant behavior of pheochromocytoma. - proper clinical evaluation biochemical markers, location, size, PASS score, IHC markers.
Keywords: Pheochromocytoma, hypertension, VMA, PASS score, IHC markers
Edition: Volume 9 Issue 9, September 2020
Pages: 244 - 250
How to Cite this Article?
Dr. Asima Ajaz, Dr. Huzaifa Tak, Dr Iqbal Lone, "Pheochromocytoma - Histopathological and Clinical Update", International Journal of Science and Research (IJSR), https://www.ijsr.net/search_index_results_paperid.php?id=SR20830100222, Volume 9 Issue 9, September 2020, 244 - 250
Similar Articles with Keyword 'hypertension'
Evaluation of Pre-Donation Deferral Causes in Whole Blood Donor Population at a Tertiary Rural Health Centre
Dr. Vamseedhar Annam, Dr. NaliniMohan.C, Dr. Lakshmi.R, Dr. Mrinalini.V.R, Dr. Sivachandran
Is PCOS An Early Manifestation of the Metabolic Syndrome? A Review Article with Latest Updates in the Laboratory Diagnosis, Prevention and Management
Mirza Asif Baig
Similar Articles with Keyword 'IHC markers'
Pathologic Panorama of Glial Tumours in Atertiary Care Centre - Three Years Institutional Study
Dr. K. Vani, Dr. K. Rama
Molecular Evaluation of Subtypes of Breast Cancer by Immunohistochemical expression of Estrogen Receptor(ER), Progesterone Receptor(PR), Her2neu,Cytokeratin 5/6 and Ki 67
Shweta Mahajan, Amarjit Singh, Anita Joneja, Sudershan Kapoor